Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Werewolf Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 35 | 41 | +6 |
| Shares | 23.9M | 27.7M | +3.79M (+15.9%) |
| Value | $51.1M | $106.8M | +$55.7M (+109.0%) |
New holders (10)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 177,300 | $684.4K | 0.00% |
| Two Sigma Investments, LP | 146,736 | $566.4K | 0.00% |
| Lighthouse Investment Partners, LLC | 22,472 | $86.7K | 0.01% |
| Citadel Advisors LLC | 21,522 | $83.1K | 0.00% |
| Virtu Financial LLC | 20,383 | $79.0K | 0.01% |
| Susquehanna International Group, LLP | 14,777 | $57.0K | 0.00% |
| Jane Street Group, LLC | 14,487 | $55.9K | 0.00% |
| Camden Capital, LLC | 10,000 | $38.6K | 0.00% |
| Baystate Wealth Management LLC | 300 | $1.16K | 0.00% |
| Group One Trading, L.P. | 100 | $386 | 0.00% |
Sold out (4)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 174,724 | $373.9K |
| Tower Research Capital LLC (TRC) | 2,350 | $5.03K |
| Royal Bank of Canada | 335 | $1.00K |
| GHP Investment Advisors, Inc. | 80 | $185 |